Root coverage using a free soft tissue autograft following citric acid application. Part 1: Technique.

Cyclophosphamide versus Placebo in Scleroderma Lung Disease

Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

A. J. Tyndall, Bettina Bannert, Paolo Airó et al. · Annals of the Rheumatic Diseases · 2010 · 1.4K citations · Full text

Public Health, Biostatistics, Cardiology +14

TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia

Neil A. Bhowmick, Anna Chytil, David Plieth et al. · Science · 2004 · 1.4K citations

Life Sciences, Cell Biology, Oncology +17

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

Ulrich A. Walker, Alan Tyndall, L. Czirják et al. · Annals of the Rheumatic Diseases · 2007 · 922 citations · Full text

Life Sciences, Clinical Sciences, Immunology +17

A multicenter, prospective, randomized, double‐blind, placebo‐controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

Rachel K. Hoyles, R Ellis, Jessica Wellsbury et al. · Arthritis & Rheumatism · 2006 · 738 citations

Medicine, Pharmacology, Pharmacotherapy +13